
The European Association for Cancer Research (EACR) conference, “Liquid Biopsies 2026,” will take place in Lyon, France, from September 22–24, 2026. This conference will gather world-leading experts to explore the latest advances in circulating nucleic acids, circulating tumour cells (CTCs), and extracellular vesicles (EVs) across the entire cancer continuum.
The educational program is structured into four focused sessions – Localised Cancers, Metastatic Cancers, Technology, and Biology – to bridge technological innovation (including fragmentomics and spatial transcriptomics) with biological insights and clinical translation, ultimately aiming to accelerate the integration of liquid biopsy approaches into cancer care for improved patient outcomes.